1.Development of Inquiries Management System for medical high-value consumables in hospital
Pingyi PENG ; Zuoqi SUN ; Jiangtao JIA ; Qi HAN ; Maoyu YUAN ; Xin ZHANG
Chinese Medical Equipment Journal 1993;0(06):-
By applying Inquiries Management System for medical high-value consumables,we can rapidly and conveniently inquiry the specific name of one product,specification,price,supply channels,manufacturers and related products,doctor's name,patient's name,operation time etc,and protect the legitimate right and interests of both doctors and patients. Meanwhile,exoteric management helps to lay a good foundation for prevention of commercial bribery.
2. Generation of human monoclonal antibody Fab fragment to Zika Virus by Phage Display Technology
Runyu YUAN ; Lina SUN ; Juan SU ; Xunmin JI ; Junhe LIANG ; Maoyu CHEN ; Mifang LIANG ; Changwen KE
Chinese Journal of Experimental and Clinical Virology 2019;33(6):626-631
Objective:
In this study, phage display technology was used to construct the human anti-Zika virus(ZIKV), phage antibody library and to obtain and express the monoclonal antibody. The aim was to master the preparation and expression of human phage antibody library screening method for highly specific antibodies.
Methods:
The whole blood samples of Zika patients were collected and the lymphocytes were isolated. The RT-PCR method was used to amplify the antibody light chain and heavy chain Fab gene from lymphocyte Ig mRNA. The pComb3H system was used to construct the gene with genetic diversity Preparation of human anti-ZIKV phage antibody library. The purified antibody library was screened by using the purified ZIKV and the obtained ZIKV E protein antigen.
Results:
The monoclonal antibody Fab fragment gene was successfully obtained for the ZIKV E protein antigen. The gene can be efficiently expressed in Escherichia coli.
Conclusions
According to the sequence analysis, this study showed that the monoclonal antibody was a new human genetically engineered antibody against ZIKV, which laid the foundation for the early diagnosis of ZIKV, and obtain a specific monoclonal antibody to ZIKV for human treatment of ZIKV infection.